iPP - Integrated Pathology Partnerships Revenue and Competitors

London, UK

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • iPP - Integrated Pathology Partnerships's estimated annual revenue is currently $26.2M per year.(i)
  • iPP - Integrated Pathology Partnerships's estimated revenue per employee is $270,000

Employee Data

  • iPP - Integrated Pathology Partnerships has 97 Employees.(i)
  • iPP - Integrated Pathology Partnerships grew their employee count by -6% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$23.2M868%N/AN/A
#2
$16M660%N/AN/A
#3
$33.5M12419%N/AN/A
#4
$7.3M346%N/AN/A
#5
$27.3M1016%N/AN/A
#6
$169.4M5025%N/AN/A
#7
$17.7M7314%N/AN/A
#8
$66.8M225-7%N/AN/A
#9
$27.3M10117%N/AN/A
#10
$139.4M4137%N/AN/A
Add Company

What Is iPP - Integrated Pathology Partnerships?

Integrated Pathology Partnerships (iPP) is part of the wider Synlab group, a leading European clinical diagnostics company that provides laboratory services in 35 countries, employs more than 13,000 highly talented individuals to perform over 400 million tests per year. \r\n\r\nThe combined clinical and outsourcing resources of iPP equip it to be a strategic partner to both the NHS and independent hospitals. We assist healthcare providers and commissioners in meeting the challenges of quality, cost and rising demand in UK pathology services.\r\n\r\niPP is a team with a proven track record and unrivalled credentials. Pathology clinicians led the creation of our business, and are major shareholders. The principle of making a positive difference to patient care is at the heart of our business ethos.\r\n\r\nWe are committed to fully supporting pathology as a world class discipline that plays a key role in meeting the NHS goals of clinical integration and patient pathways.

keywords:N/A

N/A

Total Funding

97

Number of Employees

$26.2M

Revenue (est)

-6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$14.1M97-33%N/A
#2
$23.6M975%N/A
#3
$14.1M971%N/A
#4
$20.4M972%$554.9M
#5
$13.6M97-7%N/A